National Cancer Institute (NCI) Participation in RFA-AI-14-018 "U.S-South Africa Program for Collaborative Biomedical Research (U01)"

Notice Number: NOT-CA-14-031

Key Dates
Release Date: February 4, 2014

Related Announcements
RFA-AI-14-018

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to announce that the National Cancer Institute (NCI) will participate in RFA-AI-14-018, entitled "U.S-South Africa Program for Collaborative Biomedical Research (U01)." The following sections of RFA-AI-14-018 have been updated to reflect NCI's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.855, 93.856, 93.865, 93.394, 93.395 93.396

Part 2. Section II. Award Information

Funds Available and the Anticipated Number of Awards
The NIH intends to commit an estimated total of $0.8 million to fund up to 5 awards in FY 2015.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Geraldina Dominguez, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-496-3204
Email: domingug@mail.nih.gov

Financial/Grants Management Contact(s)
Shane Woodward
National Cancer Institute (NCI)
Telephone: 240-276-6303
Email: woodwars@mail.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Geraldina Dominguez, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-496-3204
domingug@mail.nih.gov

Julie Schneider, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5795
Email: schneidj@mail.nih.gov